Elanco Animal Health Incorporated (ELAN) News
Follow Elanco Animal Health Incorporated (ELAN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 16 public stories across 13 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Elanco Animal Health Reports Q2 2026 Results: Full Earnings Call Transcript
Elanco Animal Health (NYSE: ELAN ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial d
LIVE | Oct 08, 2026, 08:29 AM UTC
L
Weekly Recap: 3yr growth, leverage cut and Befrena supply ramp, debt focus
Elanco Animal Health, Inc. (NYSE:ELAN) laid out a three-year plan for mid-single-digit revenue, stronger EBITDA and EPS growth and ~$1B cash, while boosting Befrena production after U.S. shortfalls, rolling out Quattro a
EARNINGS | Sep 28, 2026, 11:07 AM UTC
L
ELAN - Elanco to Participate in BofA Securities Global Healthcare Conference 2026
ELAN - Elanco to Participate in BofA Securities Global Healthcare Conference 2026
NEWS | Sep 17, 2026, 11:57 AM UTC
L
ELAN - Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care
ELAN - Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care
NEWS | Sep 15, 2026, 10:29 AM UTC
M
Elanco confirms date for Q3 2026 results call
EQUITY | Sep 11, 2026, 11:58 AM UTC
L
ELAN - Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
ELAN - Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
EQUITY | Sep 10, 2026, 11:58 AM UTC
L
Elanco expands Kansas manufacturing facility for biologics
Elanco (ELAN) says it is scaling biologics capabilities via expansion of its Kansas manufacturing facility, per TradeXchange Newsdesk.
EQUITY | Aug 26, 2026, 12:31 PM UTC
M
Elanco director Lawrence Kurzius reports 40,000-share transaction
Elanco Animal Health director and officer Lawrence Erik P. Kurzius filed Form 4P for a 40,000-share transaction at $23.398, totaling $935,920.
REGULATION | Aug 21, 2026, 08:17 PM UTC
H
Elanco, Eli Lilly report strong Q2 results, raise guidance
Elanco Animal Health reported better-than-expected second-quarter results and raised FY26 guidance above estimates, while Eli Lilly also reported better-than-expected second-quarter results and raised FY26 sales guidance
EARNINGS | Aug 19, 2026, 11:46 AM UTC
L
INFL ELAN LLY NFLX - CNBC Halftime final trades
INFL ELAN LLY NFLX - CNBC Halftime final trades
EQUITY | Aug 18, 2026, 05:00 PM UTC
M
Elanco director Michael J P Harrington files Form 4P
Elanco Animal Health Inc reports Form 4P activity for director/officer/10% owner Michael J P Harrington: 5,000 shares at $21.82 for $109,100.
REGULATION | Aug 13, 2026, 08:29 PM UTC
L
Elanco Sees Strong Pet Health Momentum, Bets on Innovative Products
Elanco Animal Health Incorporated (NYSE: ELAN ) delivered strong financial performance for the second quarter of 2026, driven by robust demand across its Pet Health portfolio and expanding margins. The momentum led manag
EARNINGS | Aug 05, 2026, 04:57 PM UTC
H
Wynn Resorts Posts Upbeat Q2 Earnings, Joins Bloomin' Brands, Shopify, Owens Corning And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining around 500 points on Wednesday. Shares of Wynn Resorts Ltd (NASDAQ: WYNN ) rose sharply after the company reported better-than- expected quarterly financial resul
EARNINGS | Aug 05, 2026, 02:01 PM UTC
L
Elanco Animal Health Raises FY2026 Adj EPS Guidance from $1.03-$1.09 to $1.10-$1.16 vs $1.09 Est; Raises FY2026 Sales Guidance from $5.010B
Elanco Animal Health (NYSE: ELAN ) raises FY2026 Adj EPS guidance from $1.03-$1.09 to $1.10-$1.16 vs $1.09 analyst estimate. Raises FY2026 sales outlook from $5.010 billion-$5.085 billion to $5.090 billion-$5.140 billion
EARNINGS | Aug 05, 2026, 10:29 AM UTC
L
ELAN - Elanco Animal Health Reports Second Quarter 2026 Results
ELAN - Elanco Animal Health Reports Second Quarter 2026 Results
EARNINGS | Aug 05, 2026, 10:27 AM UTC
L
Elanco Releases 2025 Impact Report
Elanco releases 2025 impact report
EQUITY | Jul 31, 2026, 11:32 AM UTC